Pacer Advisors
MED icon

Pacer Advisors’s Medifast MED Stock Holding History

Pacer Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,259,369
Closed -$48.3M – 3772
2024
Q1 		$48.3M Buy
1,259,369
+736,637
+141% +$35.7M 0.11% 200
2023
Q4 		$35.1M Buy
522,732
+201,752
+63% +$14.1M 0.1% 221
2023
Q3 		$24M Buy
320,980
+79,069
+33% +$7.01M 0.09% 218
2023
Q2 		$22.3M Buy
241,911
+95,458
+65% +$8.5M 0.09% 220
2023
Q1 		$15.2M Buy
146,453
+78,885
+117% +$8.74M 0.06% 295
2022
Q4 		$7.79M Buy
+67,568
New +$7.87M 0.04% 368
2020
Q2 		– Sell
-1,293
Closed -$84K – 973
2020
Q1 		$84K Sell
1,293
-1,436
-53% -$131K ﹤0.01% 505
2019
Q4 		$299K Buy
+2,729
New +$264K 0.01% 884

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Pacer Advisors's MED Position: Q2 2024 in Review

Pacer Advisors sold out of Medifast (MED) in Q2 2024, closing a stake of 1,259,369 shares — an estimated $48.3M sold.

Pacer Advisors first reported a position in MED in Q4 2019 and held it in 8 quarters. The position peaked at $48.3M in Q1 2024. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • Pacer Advisors reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • Pacer Advisors sold 1,259,369 Medifast shares in Q2 2024, an estimated $48.3M.
  • Pacer Advisors first reported a position in Medifast in Q4 2019 and held it in 8 quarters.
  • Pacer Advisors's Medifast position peaked at $48.3M in Q1 2024.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Pacer Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.